loader
Please Wait
Applying Filters...

Euroapi Company Header Euroapi Company Header

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about VOWYGLHOVNSCSA-NRVKWRQJSA-N, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    VOWYGLHOVNSCSA-NRVKWRQJSA-N

    DIGITAL CONTENT

    PharmaCompass

    Farmhispania Group, a leading European CDMO in HPAPI Technologies & High Potency Fermentation.

    One Pharma aims to be one of the leading generic companies in Europe.

    2D Structure
    1. Also known as: Qc4g8xs0h0, Fosravuconazole (l-lysine ethanolate), Fosravuconazole l-lysine ethanolate [mi], ((1r,2r)-2-(4-(4-cyanophenyl)-2-thiazolyl)-1-(2,4-difluorophenyl)-1-(1h-1,2,4-triazol-1-ylmethyl)propoxy) methyl ester compound with lysine, ethanolate (1:1:1), L-lysine, compd. with 4-(2-((1r,2r)-2-(2,4-difluorophenyl)-1-methyl-2-((phosphonooxy)methoxy)-3-(1h-1,2,4-triazol-1-yl)propyl)-4-thiazolyl)benzonitrile and ethanol (1:1:1), Fosravuconazole l-lysine ethanolate (jan)
    Molecular Formula
    C31H40F2N7O8PS
    Molecular Weight
    739.7  g/mol
    InChI Key
    VOWYGLHOVNSCSA-NRVKWRQJSA-N
    FDA UNII
    QC4G8XS0H0
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    [(2R,3R)-3-[4-(4-cyanophenyl)-1,3-thiazol-2-yl]-2-(2,4-difluorophenyl)-1-(1,2,4-triazol-1-yl)butan-2-yl]oxymethyl dihydrogen phosphate;(2S)-2,6-diaminohexanoic acid;ethanol
    2.1.2 InChI
    InChI=1S/C23H20F2N5O5PS.C6H14N2O2.C2H6O/c1-15(22-29-21(10-37-22)17-4-2-16(9-26)3-5-17)23(11-30-13-27-12-28-30,34-14-35-36(31,32)33)19-7-6-18(24)8-20(19)25;7-4-2-1-3-5(8)6(9)10;1-2-3/h2-8,10,12-13,15H,11,14H2,1H3,(H2,31,32,33);5H,1-4,7-8H2,(H,9,10);3H,2H2,1H3/t15-,23+;5-;/m00./s1
    2.1.3 InChI Key
    VOWYGLHOVNSCSA-NRVKWRQJSA-N
    2.1.4 Canonical SMILES
    CCO.CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(CN3C=NC=N3)(C4=C(C=C(C=C4)F)F)OCOP(=O)(O)O.C(CCN)CC(C(=O)O)N
    2.1.5 Isomeric SMILES
    CCO.C[C@@H](C1=NC(=CS1)C2=CC=C(C=C2)C#N)[C@](CN3C=NC=N3)(C4=C(C=C(C=C4)F)F)OCOP(=O)(O)O.C(CCN)C[C@@H](C(=O)O)N
    2.2 Other Identifiers
    2.2.1 UNII
    QC4G8XS0H0
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. F-rvcz

    2.3.2 Depositor-Supplied Synonyms

    1. Qc4g8xs0h0

    2. Fosravuconazole (l-lysine Ethanolate)

    3. Fosravuconazole L-lysine Ethanolate [mi]

    4. ((1r,2r)-2-(4-(4-cyanophenyl)-2-thiazolyl)-1-(2,4-difluorophenyl)-1-(1h-1,2,4-triazol-1-ylmethyl)propoxy) Methyl Ester Compound With Lysine, Ethanolate (1:1:1)

    5. L-lysine, Compd. With 4-(2-((1r,2r)-2-(2,4-difluorophenyl)-1-methyl-2-((phosphonooxy)methoxy)-3-(1h-1,2,4-triazol-1-yl)propyl)-4-thiazolyl)benzonitrile And Ethanol (1:1:1)

    6. Fosravuconazole L-lysine Ethanolate (jan)

    7. Fosravuconazole L-lysine Ethanolate [jan]

    8. 914361-45-8

    9. L-lysine, Compd. With 4-[2-[(1r,2r)-2-(2,4-difluorophenyl)-1-methyl-2-[(phosphonooxy)methoxy]-3-(1h-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]benzonitrile And Ethanol (1:1:1)

    10. Unii-qc4g8xs0h0

    11. E-1224 L-lysine Ethanolate

    12. Bms-379224 L-lysine Ethanolate

    13. Hy-16779b

    14. Cs-0145609

    15. D10762

    16. Fosravuconazole L-lysine Ethanolate [who-dd]

    17. (s)-2,6-diaminohexanoic Acid (((2r,3r)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,4-difluorophenyl)-1-(1h-1,2,4-triazol-1-yl)butan-2-yl)oxy)methyl Dihydrogen Phosphate And Ethanol Salt

    2.4 Create Date
    2016-01-22
    3 Chemical and Physical Properties
    Molecular Weight 739.7 g/mol
    Molecular Formula C31H40F2N7O8PS
    Hydrogen Bond Donor Count6
    Hydrogen Bond Acceptor Count17
    Rotatable Bond Count15
    Exact Mass739.23647576 g/mol
    Monoisotopic Mass739.23647576 g/mol
    Topological Polar Surface Area281 Ų
    Heavy Atom Count50
    Formal Charge0
    Complexity967
    Isotope Atom Count0
    Defined Atom Stereocenter Count3
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count3
    Post Enquiry
    POST ENQUIRY